Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2019 | FINGER study future: a harmonized, global network

Alina Solomon • 20 Mar 2019
ARUK 2019
Dementia Mild Cognitive Impairment
FINGER

Alina Solomon, MD, PhD, of University of Eastern Finland, Kuopio, Finland, speaks at the Alzheimer’s Research UK (ARUK) Conference 2019, held in Harrogate, UK, where she discusses the future of the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER; NCT01041989) study. The worldwide (WW-)FINGERS network is aiming to transform the project into a global, harmonized network.

More from Alina Solomon

The first network of multidomain dementia prevention: World-Wide FINGER trials
1:29
The first network of multidomain dementia prevention: World-Wide FINGER trials
Alina Solomon • 18 Jul 2023
Digitally enhanced E-FINGER interventions for the prevention of dementia
1:15
Digitally enhanced E-FINGER interventions for the prevention of dementia
Alina Solomon • 18 Jul 2023
Contextualizing the World-Wide FINGER trials in the real-world
1:16
Contextualizing the World-Wide FINGER trials in the real-world
Alina Solomon • 18 Jul 2023
Genetic risk scores and neuroimaging changes in the FINGER trial
1:28
Genetic risk scores and neuroimaging changes in the FINGER trial
Alina Solomon • 18 Jul 2023

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
The Lewy Body Society's mission and impact
2:38
The Lewy Body Society's mission and impact
Jacqui Cannon • 5 Aug 2026
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
2:44
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
Jacqui Cannon • 5 Aug 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals